Literature DB >> 11241272

Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection.

S Scheiblhofer1, D Chen, R Weiss, F Khan, S Mostböck, K Fegeding, W W Leitner, J Thalhamer, J A Lyon.   

Abstract

The C terminus of the circumsporozoite protein (CSP) is anchored to the parasite cell membrane by a glycosylphosphatidylinositol (GPI) glycolipid. This GPI signal sequence functions poorly in heterologous eukaryotic cells, causing CSP retention within internal cell organelles during genetic immunization. Cellular location of antigen has quantitative and qualitative effects on immune responses induced by genetic immunization. Removal of the GPI signal sequence had a profound effect on induction and efficacy of CSP-specific immune response after genetic immunization of BALB/c mice with a gene gun. The CSP produced from the plasmid lacking the GPI anchor signal sequence (CSP-A) was secreted and soluble, but that produced by the CSP+A plasmid was not. The CSP-A plasmid induced a highly polarized Th2 type response, in which the CSP-specific IgG antibody titer was three- to fourfold higher, and the protective effect was significantly greater than that induced by the CSP+A plasmid. Thus, these two physical forms of CSP induced quantitatively and qualitatively different immune responses that also differed in protective efficacy. Engineering plasmid constructs for proper cellular localization of gene products is a primary consideration for the preparation of optimally efficacious DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241272     DOI: 10.1002/1521-4141(200103)31:3<692::aid-immu692>3.0.co;2-y

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.

Authors:  Michael Walther; Fiona M Thompson; Susanna Dunachie; Sheila Keating; Stephen Todryk; Tamara Berthoud; Laura Andrews; Rikke F Andersen; Anne Moore; Sarah C Gilbert; Ian Poulton; Filip Dubovsky; Eveline Tierney; Simon Correa; Angela Huntcooke; Geoffrey Butcher; Jack Williams; Robert E Sinden; Adrian V S Hill
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein.

Authors:  Aneesh Vijayan; Carmen E Gómez; Diego A Espinosa; Alan G Goodman; Lucas Sanchez-Sampedro; Carlos Oscar S Sorzano; Fidel Zavala; Mariano Esteban
Journal:  J Immunol       Date:  2012-05-21       Impact factor: 5.422

Review 3.  Genetic vaccination approaches against malaria based on the circumsporozoite protein.

Authors:  Sandra Scheiblhofer; Richard Weiss; Josef Thalhamer
Journal:  Wien Klin Wochenschr       Date:  2006       Impact factor: 1.704

4.  Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.

Authors:  Bhavna Chawla; Babita Mahajan; Miranda Oakley; Victoria F Majam; Arnel Belmonte; Martha Sedegah; Richard L Shimp; David C Kaslow; Sanjai Kumar
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

5.  Mapping immunogenic epitopes of an adhesin-like protein from Methanobrevibacter ruminantium M1 and comparison of empirical data with in silico prediction methods.

Authors:  Sofia Khanum; Vincenzo Carbone; Sandeep K Gupta; Juliana Yeung; Dairu Shu; Tania Wilson; Natalie A Parlane; Eric Altermann; Silvia M Estein; Peter H Janssen; D Neil Wedlock; Axel Heiser
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

6.  Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.

Authors:  Wolfgang W Leitner; Elke S Bergmann-Leitner; Evelina Angov
Journal:  Malar J       Date:  2010-05-27       Impact factor: 2.979

7.  A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria.

Authors:  Stephen A Kaba; Clara Brando; Qin Guo; Christian Mittelholzer; Senthilkumar Raman; David Tropel; Ueli Aebi; Peter Burkhard; David E Lanar
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

8.  From sequence to antibody: genetic immunisation is suitable to generate antibodies against a rare plant membrane protein, the KAT 1 channel.

Authors:  Renate Gehwolf; Richard Weiss; Maximilian Gabler; Annette C Hurst; Adam Bertl; Josef Thalhamer; Gerhard Obermeyer
Journal:  FEBS Lett       Date:  2007-01-16       Impact factor: 4.124

9.  Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei.

Authors:  Elke S Bergmann-Leitner; Ryan M Mease; Patricia De La Vega; Tatyana Savranskaya; Mark Polhemus; Christian Ockenhouse; Evelina Angov
Journal:  PLoS One       Date:  2010-08-19       Impact factor: 3.240

10.  Computational and experimental validation of B and T-cell epitopes of the in vivo immune response to a novel malarial antigen.

Authors:  Elke S Bergmann-Leitner; Sidhartha Chaudhury; Nicholas J Steers; Mark Sabato; Vito Delvecchio; Anders S Wallqvist; Christian F Ockenhouse; Evelina Angov
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.